13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-15, with 47 holding rows worth $377,036,000.
- Accession
- 0001387131-20-004824
- Filer
- CIK 1595851
- Filed
- 2020-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2020
A holdings report, 49 entries on the cover page, a total value of $377,036,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $377,036,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 737,500 | $57,112,000 | thousands by filing date | put |
| SPY | 78462F103 | SHS | 146,700 | $37,812,000 | thousands by filing date | put |
| INVESCO QQQ TR | 46090E103 | COM | 174,200 | $33,168,000 | thousands by filing date | put |
| Health Care Select Sector SPDR Fund | 81369Y209 | SHS | 244,700 | $21,676,000 | thousands by filing date | call |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 650,000 | $20,430,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 150,000 | $16,892,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,050,000 | $14,154,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 1,305,500 | $12,755,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 215,000 | $12,648,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 2,000,000 | $11,660,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 710,000 | $11,051,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 400,000 | $10,880,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 350,000 | $10,477,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 650,000 | $9,068,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 115,000 | $8,840,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 50,000 | $7,217,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 400,000 | $5,804,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 225,000 | $4,997,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 585,000 | $4,417,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 1,725,000 | $4,157,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 2,000,000 | $4,000,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 1,500,000 | $3,960,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 150,000 | $3,710,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 325,000 | $3,686,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 825,000 | $3,333,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 80,000 | $3,224,000 | thousands by filing date | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 200,000 | $3,108,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 828,459 | $2,850,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 350,000 | $2,779,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 250,000 | $2,743,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 350,000 | $2,678,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 115,000 | $2,475,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 150,000 | $2,433,000 | thousands by filing date | |
| INVESCO CURRENCYSHARES EURO | 46138K103 | EURO SHS | 20,830 | $2,173,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 200,000 | $1,968,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 782,928 | $1,957,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 65,000 | $1,867,000 | thousands by filing date | |
| CUE BIOPHARMA INC | 22978P106 | COM | 125,000 | $1,774,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 112,695 | $1,745,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 497,074 | $1,645,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 227,827 | $1,608,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 350,000 | $1,467,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 178,109 | $1,341,000 | thousands by filing date | |
| APPLIED GENETIC TECHNOL CORP | 03820J100 | COM | 372,806 | $1,223,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 3,250 | $1,028,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 165,600 | $662,000 | thousands by filing date | call |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 208,733 | $384,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-20-004824 | this filing | 2020-05-15 | acceptance time not in the bulk data set |